This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Advertisement Advertisement Advertisement
Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit September 21, 2015

Education   News & Publications   Grants & Research   Advocacy   Resources   About ASTS

 




Psychosocial predictors of mortality following lung transplantation
American Journal of Transplantation (login required)
Lung transplantation has become an increasingly common treatment for patients with end-stage lung disease. Few studies have examined psychosocial risk factors for mortality in transplant recipients, despite evidence suggesting that elevated levels of negative affect are associated with greater mortality following major cardiac surgery. We therefore examined the relationship between negative affect early after lung transplantation and long-term survival in a sample of 132 lung transplant recipients (28 cystic fibrosis, 64 chronic obstructive pulmonary disease, 26 idiopathic pulmonary fibrosis, 14 other) followed for up to 13.5 years (median 7.4 years) following transplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SOCIETY NEWS


New ASTS recognition award: Rising Stars
ASTS
ASTS has established the Rising Stars in Transplantation Surgery Award, which gives recognition from the leading Society of transplantation surgery that these individuals have made a significant, profound, or potentially transformative contribution to the discipline.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Last call for ASTS Leadership Development Program
ASTS
There's still room for you in the 2015 Leadership Development Program Sept. 27-30. This course is the only one of its kind, combining specific case studies and expertise in transplantation with experts in leadership and organizational topics from Northwestern's Kellogg School of Management.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Registration open for ASTS 2016 Winter Symposium
ASTS
As more patients suffer due to the shortage of life-saving donor organs each year, ASTS is focusing its Winter Symposium on innovative science and effective public policy to combat this crisis. Register today to join us in Miami Jan. 14-17, 2016, to learn what is being done to save lives through expanding organ transplantation—and how you can help.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TOP NEWS


Financial impact of liver sharing and organ procurement organizations' experience with Share 35: Implications for national broader sharing
American Journal of Transplantation (login required)
The Share 35 policy for organ allocation, which was adopted in June 2013, allocates livers regionally for candidates with Model for End-Stage Liver Disease scores of 35 or greater. The authors analyzed the costs resulting from the increased movement of allografts related to this new policy. Using a sample of nine organ procurement organizations, representing 17 percent of the US population and 19 percent of the deceased donors in 2013, data were obtained on import and export costs before Share 35 implementation (June 15, 2012, to June 14, 2013) and after Share 35 implementation (June 15, 2013, to June 14, 2014).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


Liver transplantation from living donors with Gilbert's syndrome is a safe procedure for both donors and recipients
Clinical Transplantation (login required)
Liver transplantation (LT) has become a favorable therapeutic option for patients with end-stage liver diseases. Gilbert's syndrome (GS) is a benign condition characterized by intermittent mild jaundice due to unconjugated hyperbilirubinemia. It is not obvious whether living-donor liver transplantation (LDLT) from a donor with GS could result in a normal outcome for both the recipient and the donor.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




HCC exception policy for liver transplant reduces survival benefit for patients with HCC
Healio
Researchers from the Veterans Affairs Puget Sound Health Care System, Seattle, Washington, found that the hepatocellular carcinoma MELD exception policy reduces liver transplantation-related survival benefit in patients with hepatocellular carcinoma, according to published findings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of ASTS NewsBrief? Click here to visit the ASTS NewsBrief archive page.


UDCA reduces risk for recurrent cirrhosis after liver transplantation
Healio
Liver transplant recipients treated with ursodeoxycholic acid had a lower risk for recurrent primary biliary cirrhosis, according to published findings in the Journal of Hepatology. Researchers collected and analyzed data of 90 patients enrolled across five French and Swiss transplant centers between 1988 and 2010 who underwent liver transplant for primary biliary cirrhosis (PBC). Nineteen patients underwent preventive therapy with 10 mg/kg to 15 mg/kg ursodeoxycholic acid (UDCA) daily.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cell transplantation procedure may one day replace liver transplants
Medical Xpress
Liver transplantation is currently the only established treatment for patients with end stage liver failure. However, this treatment is limited by the shortage of donors and the conditional integrity and suitability of the available organs. Transplanting donor hepatocytes (liver cells) into the liver as an alternative to liver transplantation also has drawbacks as the rate of survival of primary hepatocytes is limited and often severe complications can result from the transplantation procedure.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASTS NewsBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of the ASTS NewsBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 7, 2015
Aug. 24, 2015
Aug. 10, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063